Back to results
CompletedPhase 2

Clinical- and Immunological Activity, Safety and Tolerability of Different Doses / Formulations of AFFITOPE AD02 in Early Alzheimer's Disease

NCT01117818

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Landeskrankenhaus Hall Gedächtnisambulanz

Hall in Tirol, Austria

+30 additional locations

View on ClinicalTrials.gov
Clinical- and Immunological Activity, Safety and Tolerability of Different Doses / Formulations of AFFITOPE AD02 in Early Alzheimer's Disease — TrialFind